טוען...
New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
Patients with acute coronary syndrome (ACS) usually receive acetylsalicylic acid plus an adenosine diphosphate (ADP) receptor inhibitor to reduce the long‐term risk of recurrent events. However, patients receiving standard antiplatelet prophylaxis still face a substantial risk of recurrent events. S...
שמור ב:
| הוצא לאור ב: | Clin Cardiol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley Periodicals, Inc.
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6649494/ https://ncbi.nlm.nih.gov/pubmed/24452610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22233 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|